Assignee
SALIOGEN THERAPEUTICS INC
US·2 granted patents·8 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
10 records- 0171US11993784B2Transposition-based therapiesSALIOGEN THERAPEUTICS INC·Filed 2023·Granted May 28, 2024·0 cites·28 claims
- 0266US11542528B2Transposition-based therapiesSALIOGEN THERAPEUTICS INC·Filed 2022·Granted Jan 3, 2023·0 cites·28 claims
- 0365US2023250453A1Transposition-based therapiesSALIOGEN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0456US2025207111A1Mobile genetic elements from eptesicus fuscusSALIOGEN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0552US2025002876A1Mobile elements and chimeric constructs thereofSALIOGEN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0649US2025011736A1Transposable mobile elements with enhanced genomic site selectionSALIOGEN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0747US2025011720A1Manufacturing of stem cellsSALIOGEN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0845US2024002818A1Mammalian mobile element compositions, systems and therapeutic applicationsSALIOGEN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0943US2023193319A1Compositions and methods for treatment of inherited macular degenerationSALIOGEN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1043US2023173103A1Compositions and methods for treatment of familial hypercholesterolemia and elevated low-density lipoprotein cholesterolSALIOGEN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →